The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity. (Q52935906)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Davinder S Jassal

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1

Kimberly-Ann Bordun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

3

Megan daSilva

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Sheena Premecz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Soma Mandal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Vineet Goyal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Tamara Glavinovic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Matthew Cheung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

David Cheung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Christopher W White

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Rakesh Chaudhary

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Hector R Villarraga

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Joerg Herrmann

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Manish Kohli

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Amir Ravandi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

James Thliveris

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Marshall Pitz

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Pawan K Singal

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sharon Mulvagh

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

19 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology Heart and Circulatory Physiology

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

H692-701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26092985%20AND%20SRC:MED&resulttype=core&format=json

Myocardial regulatory proteins and heart failure

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Cardiovascular toxicity caused by cancer treatment: strategies for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Role of biomarkers in cardioncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Sunitinib: from rational design to clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Echocardiography and vascular ultrasound: new developments and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Validation of volume-pressure recording tail-cuff blood pressure measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Heart failure associated with sunitinib: lessons learned from animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Recognizing and managing left ventricular dysfunction associated with therapeutic inhibition of the vascular endothelial growth factor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Natriuretic peptides and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

A clinicopathologic analysis of adriamycin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Increasingly sensitive assays for cardiac troponins: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Inflammatory biomarkers in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Quantitative assessment of regional myocardial function in mice by tissue Doppler imaging: comparison with hemodynamics and sonomicrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Cardiovascular effects of systemic cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Cross-sectional echocardiography. III. Analysis of mathematic models for quantifying volume of symmetric and asymmetric left ventricles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Tissue Doppler imaging a new prognosticator for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015

A High-Lipid Diet Potentiates Left Ventricular Dysfunction in Nitric Oxide Synthase 3-Deficient Mice after Chronic Pressure Overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00172.2015